Differentiated Thyroid Cancer Genetic Mechanisms - Focus on Vitamin D Receptor and Methylenetetrahydrofolate Reductase Gene Polymorphisms [PDF]
Modern Medicine, 2022 Thyroid cancer is the most frequent endocrine cancer representing 1-1.5% of all cancers. Approximately 90% of these are differentiated thyroid carcinomas (DTC) with a favorable prognosis and cure rate.
Andra-Maria COCOLOS, Catalina POIANA
doaj +1 more source
Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer [PDF]
Endocrinology and Metabolism, 2021 Background Several cancers show increased levels of lactate dehydrogenase A (LDHA), which are associated with cancer progression. However, it remains unclear whether LDHA levels are associated with papillary thyroid cancer (PTC) aggressiveness or with ...
Eun Jeong Ban +8 more
doaj +1 more source
Molecular Correlates and Nuclear Features of Encapsulated Follicular-Patterned Thyroid Neoplasms [PDF]
Endocrinology and Metabolism, 2021 Background Assessing nuclear features is diagnostically challenging in the aspect of thyroid pathology. The aim of this study was to determine whether pathologists could distinguish BRAF-like and RAS-like nuclear features morphologically and identify ...
Chan Kwon Jung +10 more
doaj +1 more source
The role of preoperative levels of serum IL-6, IL-8 and TNF-α and conventional inflammatory parameters in the detection of metastatic forms of papillary thyroid cancer [PDF]
World Cancer Research Journal, 2021 Objective: Inflammation is an important part of cancer pathophysiology. Preoperative detection of inflammatory parameters like cytokines and conventional inflammatory parameters (CIP), as well as their correlation, could be helpful in early detection of ...
S. Hodzic-Redzic +3 more
doaj +1 more source
Frontiers in Oncology, 2023 Patients after kidney transplantation have a much higher risk of developing malignant tumors than the general population. And the native kidney is an organ relatively susceptible to malignant tumors after renal transplantation.
Cheng Yi +9 more
doaj +1 more source
A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol [PDF]
Endocrinology and Metabolism, 2020 Background Radioactive iodine (RAI) remnant ablation is recommended in patients with papillary thyroid cancer (PTC) and extrathyroidal extension or central lymph node metastasis.
Eun Kyung Lee +11 more
doaj +1 more source
Frontiers in Oncology, 2021 PurposeTo assess the association of tumor architecture with cancer recurrence, metastasis, and cancer-specific survival (CSS) in patients treated with radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC) in Taiwan ...
Hui-Ying Liu +12 more
doaj +1 more source
Radionuclide therapy in the treatment of thyroid malignancy [PDF]
Archive of Oncology, 2003 In this paper we presented the principles of performance of radionuclide therapy, its adverse effect, together with mentioned complications obligation to use it only according to directions and the success of the therapy, which is seen through the length
Malešević Milica Đ.
doaj +1 more source
Applied Sciences, 2020 Papillary thyroid microcarcinoma (PTMC) is a common malignant disease of the endocrine system, which has rapidly increased in incidence and prevalence in recent decades.
Radu Danila +7 more
doaj +1 more source
Annals of Urologic Oncology, 2023 A 50-year-old male presented with abdominal pain, pain during defaecation, constipation, bleeding per rectum for 2 months. Colonoscopy showed an ulcero-proliferative growth, that is 2.5 cm from anal verge. Further PET-CT confirmed the growth in the lower
Sivaranjani Selvaraj +3 more
doaj +1 more source